CN102988576B - Preparation method and application of nine-ingredient notopterygium root tablets - Google Patents
Preparation method and application of nine-ingredient notopterygium root tablets Download PDFInfo
- Publication number
- CN102988576B CN102988576B CN201210378427.6A CN201210378427A CN102988576B CN 102988576 B CN102988576 B CN 102988576B CN 201210378427 A CN201210378427 A CN 201210378427A CN 102988576 B CN102988576 B CN 102988576B
- Authority
- CN
- China
- Prior art keywords
- sheet
- preparation
- ingredients containing
- extraction
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004615 ingredient Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 24
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 238000000874 microwave-assisted extraction Methods 0.000 claims abstract description 11
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 10
- 230000004663 cell proliferation Effects 0.000 claims abstract description 9
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 55
- 238000000605 extraction Methods 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 9
- 210000005265 lung cell Anatomy 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 5
- 230000000274 adsorptive effect Effects 0.000 claims description 5
- 229940126678 chinese medicines Drugs 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 abstract description 10
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 abstract 1
- 229940015301 baicalein Drugs 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 229960004756 ethanol Drugs 0.000 description 21
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 10
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 10
- 229960003321 baicalin Drugs 0.000 description 10
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- JWHHANVGNNWIRI-UHFFFAOYSA-N methanol phosphoric acid hydrate Chemical compound O.OC.OP(O)(O)=O JWHHANVGNNWIRI-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a method for preparing nine-ingredient notopterygium root tablets. The nine-ingredient notopterygium root tablets are prepared by carrying out supercritical extraction and microwave-assisted extraction on the raw material medicines: 150g of notopterygium root, 150g of divaricate saposhnikovia root, 150g of rhizoma atractylodis, 50g of wild ginger, 100g of szechuan lovage rhizome, 100g of radix angelicae, 100g of radix scutellariae, 100g of liquorice, 100g of rehmannia. Therefore, the content of baicalein is greatly improved. The invention also provides application of the nine-ingredient notopterygium root tablets in preparation of medicines for suppressing human cytomegalovirus A549 cell proliferation.
Description
Technical field
The present invention relates to the Chinese medicine preparation technical field, be specifically related to a kind of preparation method and application of nine ingredients containing notopterygium sheet.
Background technology
The nine ingredients containing notopterygium sheet is recorded in Ministry of Public Health standard WS3-B-0876-91, is made the dehumidifying of inducing sweat as crude drug by Rhizoma Et Radix Notopterygii 150g, Radix Saposhnikoviae 150g, Rhizoma Atractylodis 150g, Herba Asari 50g, Rhizoma Chuanxiong 100g, Radix Angelicae Dahuricae 100g, Radix Scutellariae 100g, Radix Glycyrrhizae 100g, Radix Rehmanniae 100g.For fever with aversion to cold, lossless, headache xerostomia, limb aching pain.
In prior art, not yet there is the nine ingredients containing notopterygium sheet to adopt the report of supercritical and microwave technology extracting aspect preparation, and adopt the method that powder and decocting boil of beating, technique is coarse, backward, and impurity is many, causes patient's consumption excessive, be inconvenient to take, had a strong impact on this product and applied clinically.
Summary of the invention
Goal of the invention: in order to address the above problem, the object of the present invention is to provide a kind of preparation method of nine ingredients containing notopterygium sheet.
Another object of the present invention is to provide a kind of nine ingredients containing notopterygium sheet to suppress the application in human cytomegalovirus lung cell A549 cell proliferation medicine in preparation.
Technical scheme: the objective of the invention is to realize by following scheme:
A kind of preparation method of nine ingredients containing notopterygium sheet, by Rhizoma Et Radix Notopterygii 150g, Radix Saposhnikoviae 150g, Rhizoma Atractylodis 150g, Herba Asari 50g, Rhizoma Chuanxiong 100g, Radix Angelicae Dahuricae 100g, Radix Scutellariae 100g, Radix Glycyrrhizae 100g, Radix Rehmanniae 100g makes as crude drug, described method is comprised of the following step: get Rhizoma Et Radix Notopterygii, Rhizoma Atractylodis, Herba Asari, Rhizoma Chuanxiong, join in CO2 supercritical extraction device, ethanol is as entrainer, the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO2 flow 1-3m1/g crude drug min, extraction time 150-180min, obtain supercritical extract, standby, get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400-600W, extract 2 times, each 4-8 minute, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby, above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
The preparation method of above-mentioned a kind of nine ingredients containing notopterygium sheet, described CO
2the percent by volume that the supercritical extraction entrainer accounts for total extractant is 5%.
The preparation method of above-mentioned a kind of nine ingredients containing notopterygium sheet, described microwave extracting power 500W extracts 6 minutes at every turn.
The preparation method of above-mentioned a kind of nine ingredients containing notopterygium sheet, described CO
2the extracting pressure 20MPa of supercritical extraction, 40 ℃ of temperature, CO
2flow 2ml/g crude drug min, extraction time 160min.
Above-mentioned nine ingredients containing notopterygium sheet suppresses the application in human cytomegalovirus lung cell A549 cell proliferation medicine in preparation.
In prior art, every 0.5g of nine ingredients containing notopterygium sheet, each 4-5 sheet, 2-3 time on the one, every 0.5g of nine ingredients containing notopterygium sheet that employing the present invention is prepared into only needs the 2-3 sheet at every turn, within 1st, takes 2 times, has greatly reduced dose having under the condition of more active component.This conclusion can be by following evidence.
The comparison of baicalin content in nine ingredients containing notopterygium sheet prepared by test one, distinct methods
1, instrument and reagent nine ingredients containing notopterygium sheet of the present invention: press embodiment 3 method preparations, use the 1000g crude drug, through extraction, make 1000, every heavy 0.5g.Former nine ingredients containing notopterygium sheet, by the preparation of ministry standard method, used the 1000g crude drug, through extraction, makes 1000, every heavy 0.5g.Agilent 1200 high performance liquid chromatographs; The METTLERAE240 electronic analytical balance; Baicalin reference substance (Nat'l Pharmaceutical & Biological Products Control Institute).
2, method
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica, be filler; Methanol-water-phosphoric acid (40:60:0.2) is mobile phase; The detection wavelength is 280nm.Number of theoretical plate is pressed the baicalin peak and is calculated, and should be not less than 3000.
The preparation of reference substance solution: precision takes at 60 ℃ of drying under reduced pressure baicalin reference substance of 4 hours appropriate, adds methanol and makes the solution of every 1ml containing 18 μ g, obtains.
The preparation of need testing solution: get nine ingredients containing notopterygium sheet of the present invention and former nine ingredients containing notopterygium sheet, porphyrize, mix, and gets 1g, accurately weighed, and precision adds 70% ethanol 20ml, close plug, and supersound process 10 minutes, centrifugal, get supernatant, obtain.
Algoscopy is accurate reference substance solution and each 20 μ l of need testing solution of drawing respectively, and the injection liquid chromatography, measure, and obtains.
3, result
Result shows, in nine ingredients containing notopterygium sheet of the present invention, the content of baicalin is the 1.12mg/ sheet; And in former nine ingredients containing notopterygium sheet, the content of baicalin is the 0.13mg/ sheet, in the situation that dose reduces, baicalin content improves a lot.
Above-mentioned research shows, the nine ingredients containing notopterygium sheet that adopts the present invention to prepare, the nine ingredients containing notopterygium sheet that active constituent content is standby higher than the ministry standard legal system.
The specific embodiment
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as to the scope of the above-mentioned theme of the present invention only limits to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
Embodiment 1
Get Rhizoma Et Radix Notopterygii 150g, Radix Saposhnikoviae 150g, Rhizoma Atractylodis 150g, Herba Asari 50g, Rhizoma Chuanxiong 100g, Radix Angelicae Dahuricae 100g, Radix Scutellariae 100g, Radix Glycyrrhizae 100g, Radix Rehmanniae 100g, by Rhizoma Et Radix Notopterygii, Rhizoma Atractylodis, Herba Asari, Rhizoma Chuanxiong, join in CO2 supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4%, extracting pressure 15MPa, 30 ℃ of temperature, CO2 flow 1m1/g crude drug min, extraction time 150min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400W, extract 2 times, each 4 minutes, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
After testing, in finished product, the content of baicalin is the 1.21mg/ sheet.
Embodiment 2
Get Rhizoma Et Radix Notopterygii 150g, Radix Saposhnikoviae 150g, Rhizoma Atractylodis 150g, Herba Asari 50g, Rhizoma Chuanxiong 100g, Radix Angelicae Dahuricae 100g, Radix Scutellariae 100g, Radix Glycyrrhizae 100g, Radix Rehmanniae 100g, by Rhizoma Et Radix Notopterygii, Rhizoma Atractylodis, Herba Asari, Rhizoma Chuanxiong, join CO
2in the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 6%, extracting pressure 30MPa, temperature 50 C, CO
2flow 3m1/g crude drug min, extraction time 180min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600W, extract 2 times, each 8 minutes, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
After testing, in finished product, the content of baicalin is the 1.14mg/ sheet.
Embodiment 3
Get Rhizoma Et Radix Notopterygii 150g, Radix Saposhnikoviae 150g, Rhizoma Atractylodis 150g, Herba Asari 50g, Rhizoma Chuanxiong 100g, Radix Angelicae Dahuricae 100g, Radix Scutellariae 100g, Radix Glycyrrhizae 100g, Radix Rehmanniae 100g, by Rhizoma Et Radix Notopterygii, Rhizoma Atractylodis, Herba Asari, Rhizoma Chuanxiong, join CO
2in the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5%, extracting pressure 20MPa, 40 ℃ of temperature, CO
2flow 2m1/g crude drug min, extraction time 160min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 500W, extract 2 times, each 6 minutes, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
After testing, in finished product, the content of baicalin is the 1.12mg/ sheet.
Embodiment 4: the nine ingredients containing notopterygium sheet suppresses the experimentation data of A549 cell proliferation
1 experiment material
1.1 experiment cell strain
Human cytomegalovirus lung cell A549 cell, Nanjing Zhengkuan Pharmaceutical Technology Co., Ltd.'s laboratory cell bank, DMEM+10%FBS cellar culture.
1.2 Experimental agents
Drugs: nine ingredients containing notopterygium sheet of the present invention: press embodiment 3 method preparations.
The medicinal liquid liquid storage: take 100mg nine ingredients containing notopterygium sheet, be dissolved in the 5ml dehydrated alcohol, 0.2 μ m filter filters, 500 μ ldoff pipe packing, and-20 ℃ of storages, 0.2 μ m filter filters the use of dehydrated alcohol in order to matched group simultaneously.
1.3 experiment reagent
The Cat.No.12100-061 Lot.No.758137 of DMEM(GIBCO company); Hyclone (Hangzhoupro, sky, Zhejiang bio tech ltd Lot.No.100419); NaHCO3(Shanghai hundred million chemical reagent company limited Cat.No.11810-033 Lot.No.1088387 of a specified duration); Trypsin(AMRESCO company lot number: 2010/04); EDTA(AMRESCO company lot number: 2009/10); Penicillin G Sodium Salt(AMRESCO company lot number: 2010242); Streptomycin Sulfate(AMRESCO company lot number: 2010382); Dehydrated alcohol (Nanjing Chemistry Reagent Co., Ltd.'s lot number: 080310182); MTT (Biosharp lot number: 0793); The autogamy of PBS(laboratory);
1.4 experiment equipment
Lycra inverted microscope (German Leica model: DM1L); Visible-ultraviolet light microwell plate detector (U.S. MD company model: SPECTRAMAX 190); CO2 incubator (FORMA model: 3111); (safe and sound company of Su Jing group manufactures model to super-clean bench: SW-CJ-ZFD); Pure water instrument (U.S. Spring company model: S/N 020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Table electrothermal air dry oven (Shanghai accurate experimental facilities company model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μ m filter (MILLIPORE model: SLGP033RB); 10cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2 experimental techniques
1) the A549 cell carries out cellar culture (10cm culture dish) with DMEM+10%FBS in 37 ℃, 5%CO2, when Growth of Cells during to logarithmic (log) phase, collecting cell, discard culture fluid, PBS fine laundering 3 times, add 3ml 0.25% trypsin-0.04%EDTA, after 37 ℃ of digestion 2min, add wherein 5ml complete medium neutralization reaction, after the piping and druming cell, it is proceeded in centrifuge tube, the centrifugal 5min of 1000rpm, adjust 3 * 104/ml of concentration of cell suspension.
2) the cell kind is entered in 96 well culture plates, every hole adds cell suspension 180 μ l, culture plate put into cell culture incubator (37 ℃, 5%CO2) cellar culture.
3) according to the Growth of Cells situation, generally grow to 50%-70%, add nine ingredients containing notopterygium sheet solution, continue to cultivate 24h.
4) add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT) after 24h, continue to cultivate 4h.
5) after 4h, the buckle method is removed supernatant, with absorbent paper, pats dry gently, and every hole adds 200 μ l dimethyl sulfoxide, puts low-speed oscillation 10min on shaking table, and crystal is fully dissolved.Measure the light absorption value in each hole at enzyme-linked immunosorbent assay instrument 490nm place.
6) background (do not add cell, only add culture fluid) is set simultaneously, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide), set 6 multiple holes for every group.
7) with medicine, the suppression ratio to cell means result:
Cell increment suppression ratio (%)=(control wells OD value-dosing holes OD value)/control wells OD value * 100%.Experiment repeats 3 times.
3 statistical dispositions
Adopt correlation analysis and Student t check in Microsoft Excel 2003 softwares, data mean with mean ± S.D..
4 experimental results
Statistical result showed after the mtt assay experiment, with matched group, compare, when dosage reaches 5mg/ml, to A549 cell inhibitory effect variant (P<0.05), dosage this difference when 10mg/ml has significance (P<0.01), and utmost point significant difference (P<0.001) is arranged when dosage reaches 15-20mg/ml.
Table 1 nine ingredients containing notopterygium sheet affects and grinds the A549 cell inhibitory effect
Annotate: compare * P<0.01 with matched group; * P<0.001
5 experiment conclusion
The nine ingredients containing notopterygium sheet can suppress the A549 cell proliferation, reduces the Growth of Cells number of A549 cell, and this effect is dose dependent.
Claims (4)
1. a nine ingredients containing notopterygium sheet suppresses the application in human cytomegalovirus lung cell A549 cell proliferation medicine in preparation, it is characterized in that the nine ingredients containing notopterygium sheet made as crude drug by Rhizoma Et Radix Notopterygii 150g, Radix Saposhnikoviae 150g, Rhizoma Atractylodis 150g, Herba Asari 50g, Rhizoma Chuanxiong 100g, Radix Angelicae Dahuricae 100g, Radix Scutellariae 100g, Radix Glycyrrhizae 100g, Radix Rehmanniae 100g, preparation method is comprised of the following step: get Rhizoma Et Radix Notopterygii, Rhizoma Atractylodis, Herba Asari, Rhizoma Chuanxiong, join CO
2in the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO
2flow 1-3m1/g crude drug min, extraction time 150-180min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400-600W, extract 2 times, each 4-8 minute, combining extraction liquid, concentrated, be added on the D101 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
2. a kind of nine ingredients containing notopterygium sheet suppresses the application in human cytomegalovirus lung cell A549 cell proliferation medicine in preparation according to claim 1, it is characterized in that CO in the preparation method of described nine ingredients containing notopterygium sheet
2the percent by volume that the supercritical extraction entrainer accounts for total extractant is 5%.
3. a kind of nine ingredients containing notopterygium sheet suppresses the application in human cytomegalovirus lung cell A549 cell proliferation medicine in preparation according to claim 1, it is characterized in that, in the preparation method of described nine ingredients containing notopterygium sheet, microwave extracting power 500W extracts 6 minutes at every turn.
4. a kind of nine ingredients containing notopterygium sheet suppresses the application in human cytomegalovirus lung cell A549 cell proliferation medicine in preparation according to claim 1, it is characterized in that CO in the preparation method of described nine ingredients containing notopterygium sheet
2the extracting pressure 20MPa of supercritical extraction, 40 ℃ of temperature, CO
2flow 2ml/g crude drug min, extraction time 160min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210378427.6A CN102988576B (en) | 2012-10-08 | 2012-10-08 | Preparation method and application of nine-ingredient notopterygium root tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210378427.6A CN102988576B (en) | 2012-10-08 | 2012-10-08 | Preparation method and application of nine-ingredient notopterygium root tablets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102988576A CN102988576A (en) | 2013-03-27 |
| CN102988576B true CN102988576B (en) | 2014-01-08 |
Family
ID=47918004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210378427.6A Active CN102988576B (en) | 2012-10-08 | 2012-10-08 | Preparation method and application of nine-ingredient notopterygium root tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102988576B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1363341A (en) * | 2001-01-09 | 2002-08-14 | 杨孟君 | Nano medicine 'Jiuwei Qianghuo' and its preparing process |
| CN102204986A (en) * | 2010-11-12 | 2011-10-05 | 江西普正制药有限公司 | Preparation method of notopterygium root spray of nine ingredients |
-
2012
- 2012-10-08 CN CN201210378427.6A patent/CN102988576B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102988576A (en) | 2013-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102973667B (en) | Preparation method and application of cold-fever tablet | |
| CN102988526B (en) | Method for preparing Bailing tablets and application | |
| CN102988667B (en) | Preparation method and application of tablet for regulating menstruation and activating blood | |
| CN102988577B (en) | Preparation method and application of brain-soothing hypertension pill | |
| CN102988665B (en) | Method for preparing gynecological menstruation regulating tablets and application | |
| CN102988612B (en) | Preparation method and application of tablet for clearing away heat | |
| CN102988480B (en) | Method for preparing bile and patchouli rhinitis tablets and application | |
| CN102988545B (en) | Preparation method and application of Yulian tablet | |
| CN102988502B (en) | Preparation method and application of Desheng tablet | |
| CN102988489B (en) | Preparation method and application of nose comforting tablet | |
| CN103028005B (en) | Preparation method of anti-lumbago tablet and application thereof | |
| CN102988550B (en) | Preparation method and application of qinlian tablet | |
| CN102988479B (en) | Preparation method and application of anti-dazzling tablet | |
| CN102973749B (en) | Preparation method and applications of divaricate saposhnikovia-angelica archang lica rhinitis tablets | |
| CN102988614B (en) | Preparation method and application of antiphlogosis tablet | |
| CN102988501B (en) | Preparation method and application of Libiling tablet | |
| CN102988509B (en) | Preparation method and application of bone-knitting tablet | |
| CN102988500B (en) | Method for preparing compound Dantong tablets and application | |
| CN102988611B (en) | Preparation method and application of antihypertension tablet | |
| CN102836381A (en) | Preparation method and application of middle calming tablet | |
| CN102988522B (en) | Preparation method and application of naodesheng tablets | |
| CN102988576B (en) | Preparation method and application of nine-ingredient notopterygium root tablets | |
| CN102988748B (en) | Preparation method and application of yin tonifying and blood sugar reducing tablet | |
| CN102988749B (en) | Preparation method and application of body-building tablet | |
| CN102988836B (en) | Preparation method and application of Fuganning tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 315700 Xiangshan, Zhejiang, Dandong street, Xiangshan Port Road, No. 79, No. Applicant after: Bian Yuping Address before: Lishui County of Nanjing City, Jiangsu province 211224 Jing Qiao Zhen Chen Biancun Applicant before: Bian Yuping |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD. Free format text: FORMER OWNER: BIAN YUPING Effective date: 20140703 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 315700 NINGBO, ZHEJIANG PROVINCE TO: 226100 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140703 Address after: 226100, 999, Guangzhou Road, Haimen, Jiangsu, Nantong Patentee after: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD. Address before: 315700 Xiangshan, Zhejiang, Dandong street, Xiangshan Port Road, No. 79, No. Patentee before: Bian Yuping |